Pages that link to "Q46905301"
Jump to navigation
Jump to search
The following pages link to Intermittent exposure of primitive quiescent chronic myeloid leukemia cells to granulocyte-colony stimulating factor in vitro promotes their elimination by imatinib mesylate (Q46905301):
Displaying 50 items.
- CRIF1 interacting with CDK2 regulates bone marrow microenvironment-induced G0/G1 arrest of leukemia cells (Q24336990) (← links)
- Enhanced phosphorylation of Nbs1, a member of DNA repair/checkpoint complex Mre11-RAD50-Nbs1, can be targeted to increase the efficacy of imatinib mesylate against BCR/ABL-positive leukemia cells (Q24670609) (← links)
- To wake up cancer stem cells, or to let them sleep, that is the question (Q26749632) (← links)
- Targeting RAD51 phosphotyrosine-315 to prevent unfaithful recombination repair in BCR-ABL1 leukemia (Q30010486) (← links)
- Eradication of chronic myeloid leukemia stem cells: a novel mathematical model predicts no therapeutic benefit of adding G-CSF to imatinib (Q30873646) (← links)
- Recent advances on the molecular mechanisms involved in the drug resistance of cancer cells and novel targeting therapies (Q33730375) (← links)
- The elusive chronic myeloid leukemia stem cell: does it matter and how do we eliminate it? (Q34167708) (← links)
- The Ph-positive and Ph-negative myeloproliferative neoplasms: some topical pre-clinical and clinical issues (Q34750582) (← links)
- Imatinib plus Granulocyte Colony-Stimulating Factor in Chronic Myeloid Leukemia Patients Who Have Achieved Partial or Complete Cytogenetic Response while on Imatinib (Q34832286) (← links)
- The research on the immuno-modulatory defect of Mesenchymal Stem Cell from Chronic Myeloid Leukemia patients (Q34984116) (← links)
- 5-Fluorouracil chemotherapy of gastric cancer generates residual cells with properties of cancer stem cells (Q35069199) (← links)
- Right on target: eradicating leukemic stem cells (Q35132225) (← links)
- Recent advances in cancer stem/progenitor cell research: therapeutic implications for overcoming resistance to the most aggressive cancers (Q35459525) (← links)
- Alternative approaches to eradicating the malignant clone in chronic myeloid leukemia: tyrosine-kinase inhibitor combinations and beyond (Q35931271) (← links)
- Molecular biological characteristics of the recruitment of hematopoietic stem cells from bone marrow niche in chronic myeloid leukemia (Q36375170) (← links)
- Imatinib: a review of its use in chronic myeloid leukaemia (Q36729603) (← links)
- Therapeutic targets in chronic myeloid leukaemia (Q36794538) (← links)
- Pathogenesis, treatment effects, and resistance dynamics in chronic myeloid leukemia--insights from mathematical model analyses (Q36895345) (← links)
- The therapeutic potential of the proteasome in leukaemia (Q37103852) (← links)
- Mechanisms of Disease: cancer stem cells--targeting the evil twin (Q37145857) (← links)
- Nilotinib: a phenylamino-pyrimidine derivative with activity against BCR-ABL, KIT and PDGFR kinases (Q37298638) (← links)
- Miscreant myeloproliferative disorder stem cells (Q37299267) (← links)
- Induction of cell cycle entry eliminates human leukemia stem cells in a mouse model of AML. (Q37379434) (← links)
- Persistence of leukemia-initiating cells in a conditional knockin model of an imatinib-responsive myeloproliferative disorder (Q37390598) (← links)
- Chronic myeloproliferative diseases with and without the Ph chromosome: some unresolved issues. (Q37566249) (← links)
- Critical molecular pathways in cancer stem cells of chronic myeloid leukemia (Q37767357) (← links)
- Targeting leukemic stem cells by breaking their dormancy (Q37769764) (← links)
- Mechanisms of resistance to BCR-ABL kinase inhibitors. (Q37836923) (← links)
- Chronic myeloid leukemia cells refractory/resistant to tyrosine kinase inhibitors are genetically unstable and may cause relapse and malignant progression to the terminal disease state (Q37836926) (← links)
- Hurdles Toward a Cure for CML: The CML Stem Cell (Q37952906) (← links)
- Dormancy in the stem cell niche. (Q37994916) (← links)
- Targeting cancer stem cells to suppress acquired chemotherapy resistance (Q38149736) (← links)
- Do we need more drugs for chronic myeloid leukemia? (Q38289033) (← links)
- Toward a therapeutic reduction of imatinib refractory myeloproliferative neoplasm-initiating cells (Q38311168) (← links)
- The malignancy suppression role of miR-23a by targeting the BCR/ABL oncogene in chromic myeloid leukemia (Q38957333) (← links)
- Studies on microRNAs that are correlated with the cancer stem cells in chronic myeloid leukemia (Q39037799) (← links)
- BCR-ABL1-induced expression of HSPA8 promotes cell survival in chronic myeloid leukaemia (Q39974408) (← links)
- Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity (Q41356541) (← links)
- Therapy of chronic myeloid leukaemia can benefit from the activation of stem cells: simulation studies of different treatment combinations (Q41832483) (← links)
- Role of STAT3 in Transformation and Drug Resistance in CML (Q42174918) (← links)
- G-CSF regulates hematopoietic stem cell activity, in part, through activation of Toll-like receptor signaling (Q42787187) (← links)
- Impaired immunomodulatory function of chronic myeloid leukemia cancer stem cells and the possible mechanism involved in it. (Q43932228) (← links)
- Safety and efficacy of pulsed imatinib with or without G-CSF versus continuous imatinib in chronic phase chronic myeloid leukaemia patients at 5 years follow-up (Q45047639) (← links)
- A pilot study of continuous imatinib vs pulsed imatinib with or without G-CSF in CML patients who have achieved a complete cytogenetic response. (Q46099773) (← links)
- Mathematical modeling of genesis and treatment of chronic myeloid leukemia (Q46731375) (← links)
- BCR/ABL oncogene-induced PI3K signaling pathway leads to chronic myeloid leukemia pathogenesis by impairing immuno-modulatory function of hemangioblasts. (Q53559086) (← links)
- TGF- 1-induced PI3K/Akt/NF- B/MMP9 signalling pathway is activated in Philadelphia chromosome-positive chronic myeloid leukaemia hemangioblasts (Q54615784) (← links)
- Awakening dormant haematopoietic stem cells (Q58379701) (← links)
- Targeted cancer treatment: resisting arrest (Q79196553) (← links)
- The leukaemia stem cell: similarities, differences and clinical prospects in CML and AML (Q92453398) (← links)